Immune Design (IMDZ) Tops Q3 EPS by 11c

November 9, 2016 4:48 PM EST
Get Alerts IMDZ Hot Sheet
Trade IMDZ Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Immune Design (NASDAQ: IMDZ) reported Q3 EPS of ($0.60), $0.11 better than the analyst estimate of ($0.71). Revenue for the quarter came in at $8.2 million versus the consensus estimate of $1.73 million.

For earnings history and earnings-related data on Immune Design (IMDZ) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment